Wegovy Mounjaro Dose Equivalent: Clinical Trial Results

  • Clinical trial evidence: Wegovy STEP trials showed ~15% average weight loss, Mounjaro SURMOUNT trials demonstrated ~20% results
  • Different mechanisms: Wegovy (semaglutide) targets GLP-1 only, Mounjaro (tirzepatide) activates dual GIP+GLP-1 pathways
  • Storage advantage: Wegovy remains stable 6 weeks at room temperature vs Mounjaro's 21-day limit
  • Both available from £79.99 with expert prescriber guidance and next-day cold-chain delivery
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

What Clinical Evidence Shows About Wegovy vs Mounjaro

Understanding Wegovy Mounjaro Dose Equivalent Weight Loss Results

When comparing Wegovy mounjaro dose equivalent outcomes, it's essential to understand that these medications work through different mechanisms, making direct dose comparisons challenging. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which activates both GIP and GLP-1 receptors. This dual-action approach means Mounjaro's dosing schedule and weight loss trajectory differ significantly from Wegovy's established protocol. Rather than seeking exact dose equivalents, patients should focus on each treatment's proven clinical results and individual response patterns.

UK clinical evidence demonstrates both treatments deliver substantial weight management support when used alongside a reduced-calorie diet and increased physical activity. The STEP trial programme for Wegovy and SURMOUNT studies for Mounjaro used different methodologies, patient populations, and endpoints, making head-to-head comparisons inappropriate. Instead, patients benefit from understanding each treatment's unique dosing approach, escalation schedule, and the clinical evidence supporting their individual efficacy profiles.

Wegovy Mounjaro Dose Equivalent Pricing and Value Comparison

EverydayMeds provides transparent pricing for both Wegovy and Mounjaro options, helping you understand the investment required for each treatment pathway. Wegovy pricing starts at £79.99 for the 0.25mg starter dose with discount code FIRST40 applied at checkout for new customers. The complete Wegovy escalation includes 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) provides three months of step-up dosing for £299.99, ensuring seamless progression through the initial escalation phase.

Returning customers benefit from discount code DOSE25 at checkout, whilst our 2-pen and 3-pen bundles offer supply convenience without multiple orders. The Consistency 2.4mg bundle (×2) costs £419.99, providing two months of maintenance supply, whilst our Ultimate Stability Trio (2.4mg ×3) delivers three months for £649.99. Both Wegovy and Mounjaro require similar financial commitment, though dosing frequencies and escalation timelines differ between treatments.

Clinical Evidence for Wegovy Mounjaro Dose Equivalent Outcomes

In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the landmark STEP 1 study (Wilding et al., NEJM, 2021). The STEP 3 trial demonstrated ~16% weight reduction when combined with intensive behavioural therapy, whilst STEP 5 showed ~clinically studied weight loss sustained over two years. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.

Mounjaro's SURMOUNT clinical programme evaluated tirzepatide's dual-receptor approach in separate patient populations using different trial designs and endpoints. These studies cannot be directly compared to Wegovy's STEP results due to varying methodologies, baseline characteristics, and study durations. Both treatments represent evidence-based approaches to weight management, each with robust clinical validation supporting their licensed indications and prescribing protocols.

How Wegovy Works: GLP-1 Mechanism for Weight Management

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines after eating. This prescription-only medicine works by binding to GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting feelings of satiety after smaller meals. The medication may also slow gastric emptying, helping food remain in your stomach longer and extending the feeling of fullness between meals. Clinical studies suggest Wegovy can reduce food cravings, particularly for high-calorie, palatable foods that often contribute to weight gain. This mechanism supports sustainable eating pattern changes when combined with nutritional guidance and regular physical activity. The once-weekly injection schedule helps maintain consistent GLP-1 receptor activation, supporting steady appetite regulation throughout your weight management journey.

EverydayMeds Wegovy Mounjaro Dose Equivalent Ordering Process

Our streamlined ordering process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers, registered with the General Pharmaceutical Council (#9012878), review your assessment within 3 working days as standard, or within 24 hours if you select express review. Once approved, your Wegovy is dispatched via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity throughout transit. Each order includes detailed injection instructions, dose escalation guidance, and access to ongoing clinical support throughout your treatment. Both Wegovy and Mounjaro follow similar ordering protocols, ensuring consistent pharmaceutical care regardless of which treatment your prescriber recommends.

Storage Requirements and Practical Wegovy Mounjaro Dose Equivalent Considerations

Wegovy requires refrigerated storage between 2-8°C before first use, though it can remain stable at room temperature below 30°C for up to 6 weeks once removed from refrigeration. This storage flexibility provides a significant advantage over Mounjaro, which maintains stability for only 21 days at room temperature, making Wegovy more suitable for travel or lifestyle flexibility. The FlexTouch pen design enables precise dose delivery with each weekly injection, whilst the mandatory dose escalation protocol (0.25mg→0.5mg→1mg→1.7mg→2.4mg) helps minimise gastrointestinal side effects during treatment initiation. Each pen contains 4 doses at the prescribed strength, requiring monthly prescription renewals for continued treatment. Proper injection technique and rotation of injection sites help optimise medication absorption and reduce injection site reactions. Both treatments require similar injection protocols, though their pen designs and dose escalation schedules differ significantly.

UK Weight Loss Results: Wegovy Mounjaro Dose Equivalent Real-World Outcomes

UK patients seeking wegovy mounjaro dose equivalent information often focus on real-world effectiveness beyond clinical trials, particularly how results translate to diverse populations and lifestyle factors. Post-marketing surveillance data suggests both treatments maintain clinical trial efficacy when prescribed with appropriate lifestyle interventions and ongoing medical supervision. The National Institute for Health and Care Excellence (NICE) recognises both medications within specialist weight management pathways, acknowledging their complementary roles in comprehensive obesity treatment strategies.

Individual response patterns vary significantly between patients, with factors including baseline BMI, metabolic health, adherence to dietary modifications, and concurrent medical conditions influencing outcomes. Some patients may respond more favourably to Wegovy's GLP-1-only mechanism, whilst others benefit from Mounjaro's dual-pathway approach. This variability emphasises why direct dose equivalents remain clinically inappropriate—personalised treatment selection based on individual assessment proves more valuable than attempting to match doses between fundamentally different medications.

Start Your Clinically-Supervised Weight Management Journey

Both Wegovy and Mounjaro represent evidence-based options for prescription weight management, each offering unique mechanisms and proven clinical results within their licensed indications. EverydayMeds provides access to both treatments through our GPhC-registered pharmacy (#9012878), ensuring you receive expert prescriber guidance tailored to your individual circumstances. New customers can begin with discount code FIRST40 applied at checkout, whilst returning patients use code DOSE25 for continued savings. Our clinical team remains available throughout your treatment journey, providing ongoing support and monitoring to optimise your weight management outcomes. Rather than seeking wegovy mounjaro dose equivalent matches, focus on which treatment aligns best with your health profile, lifestyle requirements, and long-term weight management goals. Explore your options with professional guidance and evidence-based care.

Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions